|
The Science and Technology
Transgenomic leverages its biomarker discovery expertise to develop and commercialize genetic tests for the detection of serious inherited cardiac diseases and to help predict drug safety, tolerability and efficacy, based on an infrastructure that includes scientific, commercial, and reimbursement capabilities in support of its marketed tests including the FAMILION® family of genetic tests for inherited heart diseases performed in a CLIA-certified laboratory. |
| |
|
 |
Customer Service
1-877-274-9432 |
|
|
